Navigation Links
Promise and Problems Signal Mixed Year Ahead for Biopharmaceutical Industry, Says Pharmaceutical Executive Magazine
Date:2/21/2013

ew innovations will be taken up in actual clinical practice," Looney said. "Payers, led by governments with significant budgetary cost exposures, are proving far more skeptical about the science and want more evidence that discoveries will not only benefit individual patients but deliver a broader public health outcome too." The forecast notes that defining such outcomes is firmly in in the eye of the beholder, which puts a premium on information that is relevant, accessible, clean and unbiased.

Delivering new products that make sense to budget conscious payers is more important than ever, as other sources of growth are under significant stress. In particular, the shine is off the so-called emerging markets of Asia and the developing world, largely because local competition to big Pharma is becoming more intense. And while it is clear that government funders in the US, Europe and Japan are tightening their pocketbooks on drug reimbursement, less is understood about the long term implications of the failure of the these critical mainstay markets to invest in the basic infrastructure for research and wise regulation that biopharma companies depend on to remain globally productive. "More than ever, the industry has to make the case for itself, which historically is a task it has neglected – the assumption is that innovation will always be rewarded," warns the Pharm Exec Forecast. "2013 is the year that so-called truth will be tested."  

For the full text of the 2013 Pharm Exec Industry Forecast, visit our web site, pharmexec.com

For further information on the magazine and our full range of information services, please contact Pharm Exec's Publisher, Russ Pratt , at rpratt@advanstar.com

Contact:
Bill Looney

'/>"/>

SOURCE Pharmaceutical Executive Magazine
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Remique (TM), a Revolutionary Dietary Supplement, Manufactured in FDA Registered Facilities, Receives Raves from Compromised Immune System Sufferers
2. Contract Research Organisations offer Promise of Innovative, Safe and Effective Drug Development, Says Frost & Sullivan
3. Oncologists in the United States and Europe Indicate that Novel Chemotherapies Hold the Most Near-Term Promise for Improving Outcomes in Soft Tissue Sarcoma
4. New Study Shows Promise For Women Needing Mesh-Augmented Pelvic Organ Prolapse (POP) Repair
5. Data Underscore Promise of Satori Pharmaceuticals Gamma-Secretase Modulator Program in Treatment of Alzheimers Disease
6. Multi-Targeted Therapies - New Wave of Combination Therapies in Late Stage Development for Lung Cancer Offer Promise
7. Satori Pharmaceuticals to Present Data Highlighting Promise of Gamma-Secretase Modulators in Treatment of Alzheimers Disease
8. Drug Delivery Technologies Show Promise of Improving Clinical Outcomes for Patients at PODD: Partnership Opportunities in Drug Delivery Conference
9. Only Podiatric Surgeon In S. Florida That Performs In-Office Ultrasound Imaging On Foot & Ankle Problems Saving Patients Over $1,000 In MRI Expenses & Extra Trip To Hospital
10. The Hygenic Corporations Custom Rubber Solutions Solve Industry Problems
11. Problems With the Stryker Rejuvenate Hip System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/17/2013)... , May 17, 2013  Lakeland Industries, Inc. ... of protective clothing for industry, healthcare and to first ... release its financial results for the fiscal 2013 fourth ... May 21, 2013 at stock market close and will ... 4:30 p.m. eastern. (Logo: http://photos.prnewswire.com/prnh/20120611/NY21959LOGO ...
(Date:5/17/2013)... 17, 2013  Orexigen® Therapeutics, Inc. (Nasdaq: OREX ... at the UBS Global Healthcare Conference in New ... 22 nd at 11 a.m. Eastern Time. To listen ... please visit the Investor Relations section of the Company,s Web ... for 14 days after the event. About Orexigen® ...
(Date:5/17/2013)... DIEGO and CAMBRIDGE, Mass., May 17, 2013 /PRNewswire/ ... that a purchaser of Aveo Pharmaceutical, Inc. (NASDAQGS: AVEO) ... Court for the District of Massachusetts ... its officers violated the Securities Exchange Act of 1934 ... 1, 2013 (the "Class Period"). (Logo: ...
Breaking Medicine Technology:Lakeland Industries to Report Fiscal Fourth Quarter and Year End Financial Results and Conduct Conference Call 2Aveo Pharmaceuticals, Inc. Sued by Investor 2Aveo Pharmaceuticals, Inc. Sued by Investor 3
(Date:5/18/2013)... (May 19, 2013) Each year, the American ... outstanding contributions and achievements in gastroenterology through its ... many distinguished and talented individuals who work tirelessly ... Today, we are pleased to announce the 2013 ... their colleagues for their tremendous contributions to our ...
(Date:5/18/2013)... 2013 Illuminations is proud to present the ... Seminars will take place over the course of four days, ... and Saturday, June 8, 2013. , Inner Child Therapy is ... on the attitudes, patterns and coping mechanisms that create the ... learn to live a more integrated and balanced life style, ...
(Date:5/18/2013)... MOOSGO.COM published an original art book for iPad ... group of artists who share their creations based on the ... Exclusively for iPad . , This work gathers ... that reflect the signature idiosyncrasy and passion of tango. Such ... Store and it includes a free trailer of the ...
(Date:5/18/2013)... In a May 14, 2013 article ... After Discovering Cancer Gene,” Fox News reported the movie ... that she carried a gene that doctors estimated gave ... a 50 percent risk of ovarian cancer (go to: ... 16, 2013 with a blog post entitled “A Patient’s ...
(Date:5/18/2013)... Transvaginal mesh lawsuits involving ... forward in a consolidated litigation underway in New Jersey’s ... to a notice on the Court’s website, the next ... will be held on Wednesday, May 22nd. Court ... the proceeding on behalf of women who suffered serious ...
Breaking Medicine News(10 mins):Health News:AGA honors distinguished clinicians, researchers and educators with prestigious recognition awards 2Health News:AGA honors distinguished clinicians, researchers and educators with prestigious recognition awards 3Health News:AGA honors distinguished clinicians, researchers and educators with prestigious recognition awards 4Health News:AGA honors distinguished clinicians, researchers and educators with prestigious recognition awards 5Health News:Illuminations Brings World Renowned Therapist to the Middle East 2Health News:New Art Book for iPad: Tango Art 2Health News:Angelina Jolie – Scarless Breast Augmentation Surgery 2Health News:Transvaginal Mesh Lawsuits: Bernstein Liebhard LLP Notes Upcoming Case Management Conference in New Jersey Ethicon Pelvic Mesh Litigation 2Health News:Transvaginal Mesh Lawsuits: Bernstein Liebhard LLP Notes Upcoming Case Management Conference in New Jersey Ethicon Pelvic Mesh Litigation 3
... , MONDAY, Nov. 2 (HealthDay News) -- Though someone ... lack basic knowledge about the potentially life-threatening disease, according ... , Diabetes is responsible for more deaths each year ... combined, but just 42 percent of those surveyed knew ...
... SINGAPORE, Nov. 2 /PRNewswire-Asia/ -- GfK Asia releases ... line with the,17th Hong Kong Optical Fair, hosted by Hong ... 2009 include China, Hong Kong, Korea,Singapore and Malaysia. The survey ... or the same in 2010. , ...
... cocoa, snuggling under blankets and heart attacks all have in ... months. , According to the Centers for Disease Control ... heart attack or similar cardiac event during or after a ... create awareness, work to lower that number, and highlight other ...
... professional athletes, who wear helmets in their careers, to help ... NEW YORK, Nov. 2 November is Epilepsy Awareness Month. ... American Epilepsy Outreach Foundation (AEOF) has joined with ... 1st Annual Helmets for Hope(TM) Campaign. The Helmets for Hope(TM) ...
... 2 In a dramatic settlement seen as a novel ... professional association, and one of the country,s biggest hospital systems ... on containing the spread of pandemics such as H1N1 "swine ... new course for limiting the spread of not only swine ...
... Preliminary evaluation after completion of treatment phase shows that, ... for patients with advanced-stage, platinum-resistant, taxane-pretreated ... AEterna Zentaris Inc. (TSX: AEZ; Nasdaq: AEZS ) ... therapy and oncology, today announced positive efficacy data from ...
Cached Medicine News:Health News:Americans Get Failing Grade on Diabetes Awareness 2Health News:Americans Get Failing Grade on Diabetes Awareness 3Health News:Asian Optical Retailers Upbeat about 2010 2Health News:Asian Optical Retailers Upbeat about 2010 3Health News:MTD Joins Forces with the AHA to Promote Heart Health 2Health News:Helmets for Hope Campaign and Gala 2Health News:Dramatic Settlement Sets National Model for H1N1 Hospital Safety Measures 2Health News:Dramatic Settlement Sets National Model for H1N1 Hospital Safety Measures 3Health News:AEterna Zentaris Announces Positive Preliminary Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Ovarian Cancer 2Health News:AEterna Zentaris Announces Positive Preliminary Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Ovarian Cancer 3Health News:AEterna Zentaris Announces Positive Preliminary Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Ovarian Cancer 4
... Full Transportability: Innovative design allows the ... in for therapy or when to ... Choose the prophylactic method to deliver ... both simultaneously. ,Automatic Garment Detection: Automatically ...
Classic black cast boot with unisex styling...
... cast boot specially lasted for fiberglass ... rocker sole for easy ambulation! ,The ... narrow last so it fits better ... and with our stretchable upper, a ...
The Multi-Purpose Medical-Surgical Shoe...
Medicine Products: